Michel Vounatsos | Chief Executive Officer |
Mike Hencke | Investor Relations |
Al Sandrock | Head of Research & Development |
Mike McDonnell | Chief Financial Officer |
Robyn Karnauskas | Analyst |
Michael Yee | Jefferies |
Cory Kasimov | JPMorgan |
Marc Goodman | SVB Leerink |
Matthew Harrison | Morgan Stanley |
Geoff Meacham | Bank of America |
Umer Raffat | Evercore |
Ronny Gal | Bernstein |
Salim Zad | Missou |
Phil Nadeau | Cowen & Company |
Good morning. My name is Shelby and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Third Quarter earnings call and financial update. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session.